Delivery Order SPE2DB20D3103-SPE2DB24FL8C5
- Not listed
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,915.95 firm-fixed-price delivery order is for the supply of Telmisartan 80 mg tablets. It is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen...
- This federal contract award is for the delivery of Telmisartan 80 mg tablets in 30-count packages. The $1,068.96 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of April 1, 2025. The award does not specify any set-aside requirements, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
- This federal contract award is for the delivery of 4562941142 Telmisartan 80 mg tablets to the Defense Logistics Agency (DLA). The $1,556.19 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 29, 2023 with a completion date of November 30, 2023. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,012.18 firm fixed-price delivery order is for the supply of 4556538401 - Telmisartan 80 mg tablets, with a period of performance through March 14, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range...
- This federal contract award is for the delivery of Telmisartan 40 mg tablets in 30-count packages, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The $4,277.67 firm fixed-price delivery order contract has an ultimate completion date of October 24, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Telmisartan 80 mg tablets, a cardiovascular medication, to the Defense Logistics Agency (DLA). The $4,599.81 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 8, 2024, with a completion date of November 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Telmisartan 80 mg tablets (30s) to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $1,796.77 delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 16, 2022. The contract has a period of performance through December 19, 2022 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,035.41 firm fixed-price delivery order is for the supply of Telmisartan 20 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of April 21, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award is for the delivery of Telmisartan 80 mg tablets to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The $5,615.71 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
- The federal contract award detailed is for the delivery of Telmisartan 40 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The prime contractor for this award is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,435.52 with a firm fixed price and a completion date of December 18, 2024. This award is not associated with a set-aside designation, indicating open competition....
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FL8C5Delivery Order
This federal contract award is for the delivery of Telmisartan 80 mg tablets to the Defense Logistics Agency (DLA). The $22,388.68 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of December 7, 2023 and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.4k | 12/6/23 |